Moreover, the proinflammatory cytokine IL-6 has been associated with increased EBV reactivation in COVID-19 patients, as significant levels of EBV viremia were found in 78% of critically ill COVID-19 patients compared to only 44.4% in non-COVID-19 patients [195]. The gene discussed is IL6; the disease is COVID-19.